WebbRibometrix is a platform therapeutics company discovering small molecule drugs that target functional 3D RNA structures to treat human diseases. Our scientific offices are located in the newly... WebbDURHAM, N.C. – January 6, 2024 – Ribometrix, Inc., today announced a strategic collaboration with Genentech, a member of the Roche Group, to discover and develop novel RNA-targeted small molecule therapeutics against several targets. Ribometrix is focused on leveraging its RNA structural expertise and analytical capabilities to make the ...
Genentech taps Ribometrix for drugs that target RNA
WebbRibometrix scientists use state-of-the-art strategies to identify ligands that bind specifically in these crevices and therapeutically modulate these RNAs. Some RNAs are important because they are messengers that carry the information necessary to synthesize a protein. Targeting these messenger RNAs means that it is possible to “drug” a ... WebbMichael Solomon has 3 current jobs including CEO at Ribometrix, Venture Partner at SV Health Investors, and COO at Ember Therapeutics. Additionally, Michael Solomon has … fidget popper with letters
News Releases - Arrakis Therapeutics
WebbSeries A - Ribometrix - 2024-11-13 - Crunchbase Funding Round Profile Funding Round Series A - Ribometrix Summary Overview Organization Name Ribometrix Announced … Webb12 jan. 2024 · Ribometrix will also be eligible to receive potential milestone payments exceeding $1 billion as well as tiered royalties on future global net sales of products that result from the collaboration ... WebbDescription. Operator of a biotechnology company committed to pioneering a completely new class of small molecule therapeutics that modulate RNA (Ribonucleic acid) biology to treat human diseases. The company's three-dimensional structural analysis of RNA drives its discovery platform for the identification of novel small molecules that ... fidget popularity